Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Haloperidol × Solutions × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pituitary Neoplasms 1 Pain 1 Neoplasms 1 Metastatic Castration-resistant Prostate Cancer (mCRPC) 1 Lung Neoplasms 1 Keratosis, Actinic 1 Hemorrhage 1 Haloperidol 1 Growth Hormone-Secreting Pituitary Adenoma 1 Brain Neoplasms 1 Anemia 1 Acromegaly 1

Interventions

Solutions 1 Haloperidol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04833023 2024-04-12

HALO Trial: Haloperidol vs Olanzapine in Hyperactive Delirium in Palliative Care Patients; A Multi-Centre, Randomised-Controlled Trial

Tan Tock Seng Hospital

Phase 3 Recruiting

Haloperidol

Data powered by HemOnc (CC BY 4.0) Colophon ⚡